- News
- News articles
- Press releases
- Scientific publications

Spermatech is financed by The Research Council of Norway. Read about Spermatech and our research in the latest issue of their news journal FUGE Nytt (norwegian).
This film from the School of Biotechnology is presented to students of secondary schools in Norway. The main goal is to encourage young people to study natural sciences. Spermatech is used as an example of a small biotechnology company situated in Norway (norwegian).
Read an interview with Eirik Næss-Ulseth, the co-founder and CEO of Spermatech AS (Norwegian).
Spermatech's collaboration with Evotec AG in Hamburg got attention in the famous weekly magazine Der Spiegel (German).
Bioworld International is a recognized newspaper which gives weekly reports about global technology developments. Spermatech's collaboration with the early drug discovery company Evotec AG attracted international attention and the story was covered in this issue of Bioworld International.
Read about Spermatech and our technology in the journal of the Norwegian Biochemical Society.
Researchers at Spermatech explain their technology on national television (Norwegian).
Stavanger Aftenblad speculates in the future human mating scene after Spermatech's success with a male contraceptive (Norwegian).
Apollon, a research magazine published by the University of Oslo has reported on Spermatech's male contraception program (Norwegian).
The Norwegian newspaper Adresseavisa wrote about Spermatech and the concept behind a male birth control pill.
The licence agreement with the University of Massachusetts Medical School (UMMS) got attention in the leading Norwegian financial newspaper Dagens Næringsliv (Norwegian).
Researchers at The University of Massachusetts Medical School (UMSS) announced their discovery of a strategy for immobilizing sperm and the agreement with Spermatech to develop a male contraceptive pill.